Veralto Wins Auction for Baird Capital's Cleanwater1

Veralto to acquire Cleanwater1 for $465M. Cleanwater1 specializes in water treatment tech, with $135M sales in the last year. Veralto expects the deal to be neutral to modestly accretive to earnings in 2027. Cleanwater1's tech complements Veralto's portfolio and expands its market reach.

Veralto (VLTO) agreed to acquire Cleanwater1 for $465M, with a net price of $452M after tax benefits. The deal, expected to close in Q4 2026, adds ~25,000 units to Veralto's portfolio, expanding its water treatment offerings. Cleanwater1 had $135M in LTM sales, growing at a low double-digit CAGR since 2023. Veralto expects the acquisition to be neutral to modestly accretive to EPS in 2027.

Veralto (NYSE:VLTO) agreed to acquire Cleanwater1 for $465M, with a net price of $452M after tax benefits. The deal, expected to close in Q4 2026, adds water treatment technologies and is projected to be neutral to modestly accretive to adjusted EPS in 2027. Cleanwater1 generated $135M in LTM sales as of June 30, 2026.

Veralto agreed to acquire Cleanwater1 for $465M in cash, with a net price of $452M. The deal, expected to close in Q4 2026, values Cleanwater1 at 17x its adjusted EBITDA. Cleanwater1 generated $135M in sales over the last 12 months, with 25% from aftermarket services. Veralto expects the acquisition to be neutral to modestly accretive to adjusted EPS in 2027.

Veralto (VLTO) agreed to acquire Cleanwater for $465 million, with a net purchase price of around $400 million after tax benefits. The deal aims to strengthen Veralto's position in water disinfection and expand its market presence.

Veralto (VLTO) will acquire Cleanwater1 for $465M, expanding its water treatment portfolio. The deal, expected to close in Q4 2026, adds 25,000 installed units and $135M in annual sales. Veralto values the acquisition at ~17x EBITDA, aiming for modest EPS accretion in 2027 and long-term growth.